John S Giuliano1, Kevin Tran, Fang-Yong Li, Veronika Shabanova, Joana A Tala, Vineet Bhandari. 1. 1Department of Pediatrics, Division of Critical Care Medicine, Yale University School of Medicine, New Haven, CT. 2Yale Center for Analytic Sciences, Yale University School of Medicine and School of Public Health, New Haven, CT. 3Pediatric Intensive Care Unit, Yale-New Haven Children's Hospital, New Haven, CT. 4Department of Pediatrics, Division of Perinatal Medicine, Department of Obstetrics/Gynecology/Reproductive Sciences, Yale University School of Medicine, New Haven, CT.
Abstract
OBJECTIVE: Capillary integrity continues to challenge critical care physicians worldwide when treating children with sepsis. Vascular growth factors, specifically angiopoietin-1 and angiopoietin-2, play opposing roles in capillary stabilization in patients with sepsis. We aim to determine whether pediatric patients with severe sepsis/shock have persistently high angiopoietin-2/1 ratios when compared with nonseptic PICU patients over a 7-day period. DESIGN: Prospective observational study. Patients were classified within 24 hours of admission into non-systemic inflammatory response syndrome, systemic inflammatory response syndrome/sepsis, or severe sepsis/shock. Plasma levels of angiopoietin-1 and angiopoietin-2 were measured via enzyme-linked immunosorbent assay. The angiopoietin-2/1 ratio was graphically plotted and determined whether patients fell into "constant" or "variable" patterns. SETTING: Tertiary care center PICU. PATIENTS: Critically ill pediatric patients with varying sepsis severity. INTERVENTIONS: None. MEASUREMENTS AND MAIN RESULTS: Forty-five patients were enrolled (nine non-systemic inflammatory response syndrome, 19 systemic inflammatory response syndrome/sepsis, and 17 severe sepsis/shock). Gender, age, weight, comorbidities, and PICU length of stay were not significantly different between the groups. Admission pediatric risk stratification scores and net fluid ins/outs were significantly elevated in the severe sepsis/shock group when compared (all p < 0.05). Admission angiopoietin-2 levels and angiopoietin-2/1 ratios were significantly different in the severe sepsis/shock group when all groups were compared (both p < 0.05). Additionally, the latter were significantly elevated in the severe sepsis/shock group at multiple time points (all p ≤ 0.05) with the peak occurring on day 2 of illness. In a separate analysis, 32% of systemic inflammatory response syndrome/sepsis and 82% of severe sepsis/shock had variable angiopoietin-2/1 ratio patterns compared with none in the control group (p < 0.001). CONCLUSIONS: Pediatric patients with severe sepsis and septic shock possess significantly elevated angiopoietin-2/1 ratios during their first 3 days of illness, which peak at day 2 of illness. A subset of these patients demonstrated variable angiopoietin-2/1 ratio patterns.
OBJECTIVE: Capillary integrity continues to challenge critical care physicians worldwide when treating children with sepsis. Vascular growth factors, specifically angiopoietin-1 and angiopoietin-2, play opposing roles in capillary stabilization in patients with sepsis. We aim to determine whether pediatric patients with severe sepsis/shock have persistently high angiopoietin-2/1 ratios when compared with nonseptic PICU patients over a 7-day period. DESIGN: Prospective observational study. Patients were classified within 24 hours of admission into non-systemic inflammatory response syndrome, systemic inflammatory response syndrome/sepsis, or severe sepsis/shock. Plasma levels of angiopoietin-1 and angiopoietin-2 were measured via enzyme-linked immunosorbent assay. The angiopoietin-2/1 ratio was graphically plotted and determined whether patients fell into "constant" or "variable" patterns. SETTING: Tertiary care center PICU. PATIENTS: Critically ill pediatricpatients with varying sepsis severity. INTERVENTIONS: None. MEASUREMENTS AND MAIN RESULTS: Forty-five patients were enrolled (nine non-systemic inflammatory response syndrome, 19 systemic inflammatory response syndrome/sepsis, and 17 severe sepsis/shock). Gender, age, weight, comorbidities, and PICU length of stay were not significantly different between the groups. Admission pediatric risk stratification scores and net fluid ins/outs were significantly elevated in the severe sepsis/shock group when compared (all p < 0.05). Admission angiopoietin-2 levels and angiopoietin-2/1 ratios were significantly different in the severe sepsis/shock group when all groups were compared (both p < 0.05). Additionally, the latter were significantly elevated in the severe sepsis/shock group at multiple time points (all p ≤ 0.05) with the peak occurring on day 2 of illness. In a separate analysis, 32% of systemic inflammatory response syndrome/sepsis and 82% of severe sepsis/shock had variable angiopoietin-2/1 ratio patterns compared with none in the control group (p < 0.001). CONCLUSIONS: Pediatric patients with severe sepsis and septic shock possess significantly elevated angiopoietin-2/1 ratios during their first 3 days of illness, which peak at day 2 of illness. A subset of these patients demonstrated variable angiopoietin-2/1 ratio patterns.
Authors: R Scott Watson; Joseph A Carcillo; Walter T Linde-Zwirble; Gilles Clermont; Jeffrey Lidicker; Derek C Angus Journal: Am J Respir Crit Care Med Date: 2002-11-14 Impact factor: 21.405
Authors: Thida Ong; Dana E McClintock; Richard H Kallet; Lorraine B Ware; Michael A Matthay; Kathleen D Liu Journal: Crit Care Med Date: 2010-09 Impact factor: 7.598
Authors: J R Gamble; J Drew; L Trezise; A Underwood; M Parsons; L Kasminkas; J Rudge; G Yancopoulos; M A Vadas Journal: Circ Res Date: 2000-09-29 Impact factor: 17.367
Authors: Daniel R Ricciuto; Claudia C dos Santos; Michael Hawkes; Lisa J Toltl; Andrea L Conroy; Nimerta Rajwans; Erin I Lafferty; Deborah J Cook; Alison Fox-Robichaud; Kamyar Kahnamoui; Kevin C Kain; Patricia C Liaw; W Conrad Liles Journal: Crit Care Med Date: 2011-04 Impact factor: 7.598
Authors: Stéphane Leteurtre; Alain Martinot; Alain Duhamel; François Proulx; Bruno Grandbastien; Jacques Cotting; Ronald Gottesman; Ari Joffe; Jurg Pfenninger; Philippe Hubert; Jacques Lacroix; Francis Leclerc Journal: Lancet Date: 2003-07-19 Impact factor: 79.321
Authors: Philipp Kümpers; Alexander Lukasz; Sascha David; Rüdiger Horn; Carsten Hafer; Robert Faulhaber-Walter; Danilo Fliser; Hermann Haller; Jan T Kielstein Journal: Crit Care Date: 2008-11-21 Impact factor: 9.097
Authors: Abhijit V Lele; Bhunyawee Alunpipatthanachai; Qian Qiu; Crystalyn Clark-Bell; Arraya Watanitanon; Anne Moore; Randall M Chesnut; William Armstead; Monica S Vavilala Journal: Dev Neurosci Date: 2019-09-25 Impact factor: 2.984
Authors: Dubravka Kojic; Benedikt H Siegler; Florian Uhle; Christoph Lichtenstern; Peter P Nawroth; Markus A Weigand; Stefan Hofer; Thorsten Brenner Journal: World J Exp Med Date: 2015-05-20
Authors: Richard W Pierce; Veronika Shabanova; Michael Canarie; Mathew Pinto; Yong Sing da Silva; Vineet Bhandari; John S Giuliano Journal: Shock Date: 2019-03 Impact factor: 3.454
Authors: Hector R Wong; Scott L Weiss; John S Giuliano; Mark S Wainwright; Natalie Z Cvijanovich; Neal J Thomas; Geoffrey L Allen; Nick Anas; Michael T Bigham; Mark Hall; Robert J Freishtat; Anita Sen; Keith Meyer; Paul A Checchia; Thomas P Shanley; Jeffrey Nowak; Michael Quasney; Arun Chopra; Julie C Fitzgerald; Rainer Gedeit; Sharon Banschbach; Eileen Beckman; Patrick Lahni; Kimberly Hart; Christopher J Lindsell Journal: PLoS One Date: 2014-01-29 Impact factor: 3.240
Authors: Kun Wang; Vineet Bhandari; John S Giuliano; Corey S O Hern; Mark D Shattuck; Michael Kirby Journal: PLoS One Date: 2014-09-25 Impact factor: 3.240
Authors: Anna Brunner; Simone Schuller; Bianca Hettlich; Eliane Marti; Anna Lehmann; Laureen M Peters; Katja-Nicole Adamik Journal: Front Vet Sci Date: 2021-06-16
Authors: Hector R Wong; Scott L Weiss; John S Giuliano; Mark S Wainwright; Natalie Z Cvijanovich; Neal J Thomas; Geoffrey L Allen; Nick Anas; Michael T Bigham; Mark Hall; Robert J Freishtat; Anita Sen; Keith Meyer; Paul A Checchia; Thomas P Shanley; Jeffrey Nowak; Michael Quasney; Arun Chopra; Julie C Fitzgerald; Rainer Gedeit; Sharon Banschbach; Eileen Beckman; Kelli Harmon; Patrick Lahni; Christopher J Lindsell Journal: PLoS One Date: 2014-03-13 Impact factor: 3.240